The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-4-{2-[5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-yl]-3-phosphonoaminoHydroxyphosphinoy-loxy-phosphonic acid-ethylsulfanyl}-butyric acid ID: ALA1791426
PubChem CID: 56638667
Max Phase: Preclinical
Molecular Formula: C15H26N7O14P3S
Molecular Weight: 653.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H]([C@@H](CNP(=O)(O)OP(=O)(O)OP(=O)(O)O)SCCC(N)C(=O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C15H26N7O14P3S/c16-6(15(25)26)1-2-40-7(3-21-37(27,28)35-39(32,33)36-38(29,30)31)11-9(23)10(24)14(34-11)22-5-20-8-12(17)18-4-19-13(8)22/h4-7,9-11,14,23-24H,1-3,16H2,(H,25,26)(H,32,33)(H2,17,18,19)(H2,21,27,28)(H2,29,30,31)/t6?,7-,9+,10-,11-,14-/m1/s1
Standard InChI Key: CISDHKHIEKDPHJ-UDYRUIFHSA-N
Molfile:
RDKit 2D
42 44 0 0 0 0 0 0 0 0999 V2000
5.0313 -3.1923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3668 -3.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5456 -8.6505 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
4.2243 -3.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1381 -2.2003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8917 -1.8648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9543 -4.6605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1738 -4.1175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4438 -2.4779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2600 -4.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2600 -8.2380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8311 -9.0630 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2600 -7.4130 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
5.5064 -5.2736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8311 -9.8880 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
3.3844 -1.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5569 -3.5057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7170 -2.3497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9745 -5.3505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2600 -6.5880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5469 -4.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1331 -7.9360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8032 -3.1702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9745 -6.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4350 -7.4130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8311 -10.7130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9581 -9.3650 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.5469 -4.1130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1339 -4.7467 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8324 -5.3505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0850 -7.4130 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0061 -9.8880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6561 -9.8880 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.3348 -6.0805 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6890 -4.9380 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.2982 -1.0443 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.2613 -5.3505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8324 -6.1755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1179 -4.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4035 -5.3505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2600 -5.7630 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
6.9519 -4.4887 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 6
3 11 1 0
4 1 1 0
5 4 2 0
6 9 2 0
7 2 1 0
8 2 1 0
9 1 1 0
10 8 1 0
11 13 1 0
12 3 1 0
13 20 1 0
14 7 1 0
15 12 1 0
16 5 1 0
17 4 1 0
18 23 1 0
10 19 1 0
20 24 1 0
21 30 1 0
22 3 2 0
23 17 2 0
24 19 1 0
25 13 2 0
26 15 2 0
27 3 1 0
28 21 2 0
7 29 1 1
30 39 1 0
31 13 1 0
32 15 1 0
33 15 1 0
14 34 1 1
35 19 1 0
36 16 1 0
37 21 1 0
38 30 1 0
39 40 1 0
40 35 1 0
19 41 1 1
6 5 1 0
14 10 1 0
16 18 2 0
10 42 1 1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 653.40Molecular Weight (Monoisotopic): 653.0471AlogP: -2.15#Rotatable Bonds: 14Polar Surface Area: 345.25Molecular Species: ZWITTERIONHBA: 16HBD: 10#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 12#RO5 Violations (Lipinski): 3CX Acidic pKa: 1.05CX Basic pKa: 9.50CX LogP: -8.52CX LogD: -13.85Aromatic Rings: 2Heavy Atoms: 40QED Weighted: 0.10Np Likeness Score: 1.09
References 1. Kappler F, Vrudhula VM, Hampton A.. (1988) Toward the synthesis of isozyme-specific enzyme inhibitors. Potent inhibitors of rat methionine adenosyltransferases. Effect of one-atom elongation of the ribose-P alpha bridge in two covalent adducts of L-methionine and beta,gamma-imido-ATP., 31 (2): [PMID:3257524 ] [10.1021/jm00397a020 ] 2. Vrudhula VM, Kappler F, Hampton A.. (1987) Isozyme-specific enzyme inhibitors. 13. S-[5'(R)-[(N-triphosphoamino)methyl]adenosyl]-L-homocysteine, a potent inhibitor of rat methionine adenosyltransferases., 30 (5): [PMID:3572977 ] [10.1021/jm00388a024 ]